Outbound Relationships |
Type |
Target |
Active |
Characteristic |
Refinability |
Group |
Values |
benzocain + butamben + tetracainhydrochlorid 14 % wt/wt/2 % wt/wt/2 % wt/wt aerosol |
Is a |
Product containing tetracaine (medicinal product) |
false |
Inferred relationship |
Some |
|
|
benzocain + butamben + tetracainhydrochlorid 14 % wt/wt/2 % wt/wt/2 % wt/wt aerosol |
Is a |
Product containing butamben (medicinal product) |
false |
Inferred relationship |
Some |
|
|
benzocain + butamben + tetracainhydrochlorid 14 % wt/wt/2 % wt/wt/2 % wt/wt aerosol |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Butamben |
false |
Inferred relationship |
Some |
|
|
benzocain + butamben + tetracainhydrochlorid 14 % wt/wt/2 % wt/wt/2 % wt/wt aerosol |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Tetracaine (substance) |
false |
Inferred relationship |
Some |
|
|
benzocain + butamben + tetracainhydrochlorid 14 % wt/wt/2 % wt/wt/2 % wt/wt aerosol |
Is a |
benzocain + butamben + tetracainhydrochlorid |
false |
Inferred relationship |
Some |
|
|
benzocain + butamben + tetracainhydrochlorid 14 % wt/wt/2 % wt/wt/2 % wt/wt aerosol |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Benzocaine (substance) |
false |
Inferred relationship |
Some |
|
|
benzocain + butamben + tetracainhydrochlorid 14 % wt/wt/2 % wt/wt/2 % wt/wt aerosol |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Tetracaine hydrochloride |
false |
Inferred relationship |
Some |
|
|
benzocain + butamben + tetracainhydrochlorid 14 % wt/wt/2 % wt/wt/2 % wt/wt aerosol |
Has manufactured dose form |
kutan OG/ELLER transdermal doseringsform |
false |
Inferred relationship |
Some |
|
|
benzocain + butamben + tetracainhydrochlorid 14 % wt/wt/2 % wt/wt/2 % wt/wt aerosol |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Butamben |
false |
Inferred relationship |
Some |
|
|
benzocain + butamben + tetracainhydrochlorid 14 % wt/wt/2 % wt/wt/2 % wt/wt aerosol |
Is a |
Product manufactured as topical dosage form |
false |
Inferred relationship |
Some |
|
|